A High-Throughput Screen to Identify LRRK2 Kinase Inhibitors for the Treatment of Parkinson's Disease Using RapidFire Mass Spectrometry.
about
Enabling Biocatalysis by High-Throughput Protein Engineering Using Droplet Microfluidics Coupled to Mass Spectrometry.A framework for large-scale metabolome drug profiling links coenzyme A metabolism to the toxicity of anti-cancer drug dichloroacetateIdentifying Inhibitors of Inflammation: A Novel High-Throughput MALDI-TOF Screening Assay for Salt-Inducible Kinases (SIKs)
P2860
A High-Throughput Screen to Identify LRRK2 Kinase Inhibitors for the Treatment of Parkinson's Disease Using RapidFire Mass Spectrometry.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A High-Throughput Screen to Id ...... g RapidFire Mass Spectrometry.
@en
type
label
A High-Throughput Screen to Id ...... g RapidFire Mass Spectrometry.
@en
prefLabel
A High-Throughput Screen to Id ...... g RapidFire Mass Spectrometry.
@en
P2093
P2860
P356
P1476
A High-Throughput Screen to Id ...... g RapidFire Mass Spectrometry.
@en
P2093
Alan Nadin
Alastair D Reith
Bill Leavens
Colin Edge
Lee Collier
Luigi Piero Stasi
Melanie Leveridge
Phil Hardwicke
Steve Ratcliffe
P2860
P304
P356
10.1177/1087057115606707
P577
2015-09-24T00:00:00Z